Researchers continue to excited about the medication , a groundbreaking dual agonist showing remarkable data in clinical trials for weight reduction . It acts by impacting both pathways : GLP-1 and https://martinatthp192148.blogproducer.com/48527427/this-new-possibility-for-body-reduction